JESSICA STRONG: Open Payments
NPI 1922548072 · SHAWNEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 20 payments from 10 companies in 2025. Trend: 2023 $15 · 2024 $38 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $98 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $79 |
| Sage Therapeutics, LLC | 3 | $59 |
| Organon LLC | 3 | $49 |
| CooperSurgical, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| MILLICENT US INC | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MYFEMBREE, ZURZUVAE, NEXPLANON, Paragard T 380A, GEMTESA, Veozah, Lynkuet, Qelbree.
Industry payments across OK — which companies pay providers there.
